Reference
[Please submit your publication]
|
Graca FA, Rai M, Hunt LC, Stephan A, Wang YD, Gordon B, Wang R, Quarato G, Xu B, Fan Y, Labelle M, Demontis F. The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy. Nat Commun (2022) 13(1) 2370
[
PubMed ID = 35501350
]
[
RRC reference
]
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
0 |
NM_135562.2 |
CG6232-RA (CG6232), mRNA |
0 |
0 |
5 |
3 |
2 |
NM_164742.1 |
CG13784-RB, transcript variant B (CG13784), mRNA |
0 |
0 |
4 |
2 |
3 |
NM_001043328.1 |
CG8144-RK, transcript variant K (ps), mRNA |
0 |
0 |
4 |
2 |
3 |
NM_001043329.1 |
CG8144-RG, transcript variant G (ps), mRNA |
0 |
0 |
4 |
2 |
3 |
NM_001043331.1 |
CG8144-RH, transcript variant H (ps), mRNA |
0 |
0 |
4 |
2 |
3 |
NM_001043327.1 |
CG8144-RF, transcript variant F (ps), mRNA |
0 |
0 |
4 |
2 |
2 |
NM_169284.2 |
CG8144-RD, transcript variant D (ps), mRNA |
0 |
0 |
4 |
2 |
2 |
NM_001043326.1 |
CG8144-RI, transcript variant I (ps), mRNA |
0 |
0 |
4 |
2 |
2 |
NM_001043330.1 |
CG8144-RJ, transcript variant J (ps), mRNA |
0 |
0 |
4 |
2 |
2 |
NM_169285.3 |
CG8144-RC, transcript variant C (ps), mRNA |
0 |
0 |
2 |
4 |
2 |
NM_058063.3 |
CG4494-RA (smt3), mRNA |
0 |
0 |
2 |
2 |
3 |
NM_140524.2 |
CG12301-RA (CG12301), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_170103.1 |
CG5394-RB, transcript variant B (Aats-glupro), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166964.1 |
CG32498-RD, transcript variant D (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166962.1 |
CG32498-RC, transcript variant C (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166966.1 |
CG32498-RM, transcript variant M (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166967.1 |
CG32498-RA, transcript variant A (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166969.1 |
CG32498-RE, transcript variant E (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166968.1 |
CG32498-RN, transcript variant N (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166970.1 |
CG32498-RG, transcript variant G (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_080322.2 |
CG32498-RF, transcript variant F (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166971.1 |
CG32498-RL, transcript variant L (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166960.1 |
CG32498-RB, transcript variant B (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166959.1 |
CG32498-RO, transcript variant O (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166961.1 |
CG32498-RI, transcript variant I (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166965.1 |
CG32498-RJ, transcript variant J (dnc), mRNA |
0 |
0 |
1 |
8 |
2 |
NM_166963.1 |
CG32498-RK, transcript variant K (dnc), mRNA |
0 |
0 |
1 |
3 |
5 |
NM_167278.1 |
CG11759-RA (Kap3), mRNA |
0 |
0 |
1 |
2 |
4 |
NM_166709.2 |
CG30428-RA (CG30428), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_165269.1 |
CG10602-RD, transcript variant D (CG10602), mRNA |
|